Mail

Junk in our genome? Re: "Junk worth keeping,"1 just because functions have been identified for some regions of genomes thought to be non-functional does not mean that all regions thought to be junk are functional. This is particularly true for bloated genomes (like the human genome) which are loaded with parasitic elements. A nearly neutral model for the evolution of eukaryotic genome structure, proposed by Michael Lynch2, suggests that mutational biases can overwhelm the cos

| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Re: "Junk worth keeping,"1 just because functions have been identified for some regions of genomes thought to be non-functional does not mean that all regions thought to be junk are functional. This is particularly true for bloated genomes (like the human genome) which are loaded with parasitic elements.

A nearly neutral model for the evolution of eukaryotic genome structure, proposed by Michael Lynch2, suggests that mutational biases can overwhelm the costs associated with many deleterious changes if population sizes are small enough. If so, many features of eukaryotic genomes (introns, elaborate transcriptional regulatory systems, etc.) would be the result of semi-neutral processes, not adaptive evolution.

Richard Meisel
The Pennsylvania State University
University Park, PA
meisel@psu.edu

As an assistant professor constantly thinking about tenure (thus, thinking about funding), I couldn't agree more with Adam Jaffe's assertion in "Double research funding? Be careful" 1 that the current funding situation is bad, frightening, terrifying, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies